Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The JointJYNT -0.22%63 Cash Ratio is 0.69 as of Mar. 2026, which is 1% below its 10-year median of 0.70. GuruFocus rates JYNT with a GF Score™ of 63/100 and a GF Value™ of $11.20 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 666 Healthcare Providers & Services companies, The Joint ranks better than 54.5% on this metric.
The Joint has a Cash Ratio of 0.69. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.
The historical rank and industry rank for The Joint's Cash Ratio or its related term are showing as below:
JYNT'
s Cash Ratio Range Over the Past 10 Years
Min: 0.42 Med: 0.7 Max: 1.15
Current: 0.69
During the past 13 years, The Joint's highest Cash Ratio was 1.15. The lowest was 0.42. And the median was 0.70.
JYNT's Cash Ratio is ranked better than 54.5% of 666
companies
in the Healthcare Providers & Services industry
Industry Median: 0.59
vs JYNT: 0.69
The Joint (NAS:JYNT) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
The Joint Cash Ratio Related Terms
The Joint Cash Ratio Historical Data
* Premium members only.
The historical data trend for The Joint's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, The Joint's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
The Joint Cash Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, The Joint's Cash Ratio distribution charts can be found below:
* The bar in red indicates where The Joint's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
The Joint (JYNT) has a Cash Ratio of 0.69 as of Mar. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on The Joint and its competitors. This is near median its historical median of 0.70. Over the past decade, The Joint's Cash Ratio has ranged from 0.42 to 1.15. According to the industry distribution chart, The Joint ranks #303 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 45.5%.
Is The Joint's Cash Ratio too high?
The Joint's current Cash Ratio of 0.69 is near median its 10-year median of 0.70. Over the past 10 years, this metric has ranged from a low of 0.42 to a high of 1.15. The Healthcare Providers & Services industry median Cash Ratio is 0.59. The Joint's value of 0.69 is 16.9% above this industry median. Based on the distribution chart, The Joint ranks #303 out of 666 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, The Joint has a GF Score™ of 63/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Joint's Cash Ratio compare to PARK and WW?
According to the Healthcare Providers & Services industry distribution chart, The Joint ranks #303 out of 666 companies for Cash Ratio. This puts The Joint in the upper half of its industry. The industry median Cash Ratio is 0.59. The Joint's value of 0.69 is 16.9% above this benchmark. Historically, The Joint's own Cash Ratio has ranged from 0.42 to 1.15 over the past decade. While the company's 10-year median is 0.70 vs. the industry median of 0.59, The Joint has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Healthcare Providers & Services company?
The median Cash Ratio among Healthcare Providers & Services companies is 0.59, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. The Joint's current Cash Ratio of 0.69 is 16.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on The Joint and its competitors. For the Healthcare Providers & Services industry, the median Cash Ratio is 0.59 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Joint's current Cash Ratio is 0.69, which is near median its own 10-year median of 0.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Joint stock overvalued right now?
Based on GuruFocus' analysis, The Joint (JYNT) is currently considered Modestly Undervalued. The stock's GF Value™ is $11.20, compared to a current price of $8.93 — trading 20.3% below its estimated fair value. The current Cash Ratio is 0.69, which is near median its 10-year median of 0.70 and 16.9% above the Healthcare Providers & Services industry median of 0.59. The Joint's overall GF Score™ is 63/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For The Joint (JYNT), the current Cash Ratio is 0.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is The Joint (JYNT) Overvalued in 2026?
Based on GuruFocus' analysis, The Joint stock appears to be undervalued.
The current stock price of $8.93 is trading 20.3% below its estimated GF Value™ of $11.20.
GuruFocus considers The Joint to be Modestly Undervalued.
Key valuation signals for JYNT:
Cash Ratio: 0.69 (near median its 10-year median of 0.70)
GF Value™: $11.20 vs. price of $8.93 (20.3% below fair value)
Industry Position: 16.9% above the Healthcare Providers & Services median (#303 of 666)
No single metric tells the full story. See the JYNT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
The Joint Corp develops, owns, operates, supports, and manages chiropractic clinics through direct ownership, management arrangements, franchising, and the sales of regional developer rights throughout the United States. The doctors of chiropractic develop personalized treatment plans to relieve patients' pain and deliver ongoing preventative care. The company has one operating business segment; The Franchise Operations segment, which is comprised of the operating activities of the franchise business unit. The Franchise Operations segment derives revenue from customers by providing access to the company's franchise license, which represents symbolic intellectual property.
63GF Score
Get the complete analysis for JYNT
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JYNT has been successfully added to your 
